Furthermore, SVCT2 knockdown endowed cholangiocarcinoma cells with treatment resistance, and the SVCT2 expression level was suggested as a positive outcome predictor for ascorbate treatment in this tumor entity [195]. Here, SLC23A2 is linked to neoplasm.